RENVELA 800MG TABLET

💊 Renvela 800 mg (Sevelamer Carbonate)

🩺 Description
Renvela 800 mg contains sevelamer carbonate, a phosphate-binding medicine used to control high blood phosphate (hyperphosphatemia) in patients with chronic kidney disease (CKD), especially those on dialysis. It works by binding phosphate from food in the digestive tract, reducing its absorption into the bloodstream.

⭐ Key Benefits

• 🩺 Lowers high blood phosphate levels
• 🦴 Helps protect bones and reduce the risk of renal bone disease
• ❤️ May help reduce complications caused by excess phosphate
• 💊 Non-calcium phosphate binder, suitable for many CKD patients

💊 Dosage

• Usually taken 3 times daily with meals.
• The starting dose is commonly 800 mg (1 tablet) or 1,600 mg (2 tablets) with each meal, depending on blood phosphate levels.
• Your doctor may adjust the dose every 2 weeks based on phosphate test results.
• Swallow the tablets whole; do not crush or chew.

📋 Uses

• ✅ Control of high phosphate levels in adults with CKD on hemodialysis or peritoneal dialysis
• ✅ May also be used in some adults with advanced CKD who are not on dialysis but have elevated phosphate levels
• ✅ Used as part of CKD management alongside dietary phosphate restriction and other treatments when needed

⚠️ Common Side Effects

• 🤢 Nausea
• 🤮 Vomiting
• 💨 Gas (flatulence)
• 💩 Constipation or diarrhea
• 🤕 Stomach pain or indigestion

Note: Seek medical attention if you develop severe constipation, persistent abdominal pain, bloody stools, or signs of bowel obstruction. Renvela should only be used under a doctor's supervision.